{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T21:45:47Z","timestamp":1776635147010,"version":"3.51.2"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"National Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.pnpbp.2025.111521","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:57:25Z","timestamp":1760101045000},"page":"111521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sex differences in ketamine treatment for depressive disorders: A systematic review"],"prefix":"10.1016","volume":"142","author":[{"given":"Ziqin","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengquan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huazhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111521_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euroneuro.2020.01.001","article-title":"Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner","volume":"32","author":"Ardalan","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114579","article-title":"Sex differences in ketamine\u2019s therapeutic effects for mood disorders: A systematic review","volume":"312","author":"Benitah","year":"2022","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s44192-024-00066-5","article-title":"Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: A pilot study","volume":"4","author":"Berner","year":"2024","journal-title":"Discover mental health"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111521_bb0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","article-title":"Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study","volume":"73","author":"Carlson","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mp.2017.241","article-title":"Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling","volume":"23","author":"Cavalleri","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jad.2019.09.010","article-title":"The NEO-FFI domain of openness to experience moderates ketamine response in treatment resistant depression","volume":"260","author":"Dale","year":"2020","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0000000000001149","article-title":"Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions","volume":"40","author":"Dale","year":"2020","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111521_bb0040","first-page":"Cd011611","article-title":"Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder","volume":"10","author":"Dean","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/15622975.2022.2097739","article-title":"Changes in adipokine concentrations in antidepressant-resistant bipolar depression after ketamine infusion and electroconvulsive therapy","volume":"24","author":"Dmitrzak-Weglarz","year":"2023","journal-title":"World Journal of Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0050","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/nar\/gkab012","article-title":"Human pathways in animal models: possibilities and limitations","volume":"49","author":"Doncheva","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jad.2017.06.043","article-title":"Low-dose ketamine for treatment resistant depression in an academic clinical practice setting","volume":"221","author":"Feifel","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","article-title":"Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \u201cdepressed\u201d mice exposed to chronic mild stress","volume":"290","author":"Franceschelli","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpsychires.2019.01.010","article-title":"Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression","volume":"110","author":"Freeman","year":"2019","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0070","author":"JPT"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111521_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/02698811211064922","article-title":"Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans","volume":"36","author":"Highland","year":"2022","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0080","article-title":"Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depression","author":"Hossein","year":"2024","journal-title":"J Psychopathol Clin Sci."},{"issue":"48","key":"10.1016\/j.pnpbp.2025.111521_bb0085","doi-asserted-by":"crossref","first-page":"eabn9494","DOI":"10.1126\/sciadv.abn9494","article-title":"The long noncoding RNA FEDORA is a cell type- and sex-specific regulator of depression","volume":"8","author":"Issler","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01268-z","article-title":"Depression treatment response to ketamine: Sex-specific role of interleukin-8, but not other inflammatory markers","volume":"11","author":"Kruse","year":"2021","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111521_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111521_bb0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","article-title":"Why is depression more common among women than among men?","volume":"4","author":"Kuehner","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13293-023-00560-5","article-title":"Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy","volume":"14","author":"Ledesma-Corvi","year":"2023","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111521_bb0115","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hbm.23085","article-title":"The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study","volume":"37","author":"Li","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jpsychires.2020.08.002","article-title":"Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence","volume":"136","author":"Lipsitz","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111521_bb0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0135","first-page":"2667","article-title":"Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review","volume":"11","author":"Nguyen","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.581360","article-title":"Sex Differences in the Sustained Effects of Ketamine on Resilience to Chronic Stress","volume":"14","author":"Okine","year":"2020","journal-title":"Front Behav Neurosci"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111521_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ijnp\/pyx081","article-title":"Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient","volume":"21","author":"Oluboka","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2023.12.033","article-title":"Clinical outcomes in the biomarkers of ketamine (bio-K) study of open-label IV ketamine for refractory depression","volume":"348","author":"Parikh","year":"2024","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104159","article-title":"Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: A retrospective cross-sectional descriptive study","volume":"99","author":"Pastuszak","year":"2024","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1415505","article-title":"Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study","volume":"15","author":"Pedraz-Petrozzi","year":"2024","journal-title":"Front Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111521_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: a Randomized Controlled Trial","volume":"176","author":"Phillips","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112153","article-title":"Rodent ketamine depression-related research: Finding patterns in a literature of variability","volume":"376","author":"Polis","year":"2019","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111521_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ijnp\/pyab082","article-title":"Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression","volume":"25","author":"Ponton","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/02698811241238284","article-title":"Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression","volume":"38","author":"Rodrigues","year":"2024","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111521_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13651501.2017.1297834","article-title":"Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression","volume":"21","author":"Rybakowski","year":"2017","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111521_bb0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.118.251652","article-title":"Sex Differences in the Pharmacokinetics of Low-dose Ketamine in Plasma and Brain of Male and Female Rats","volume":"367","author":"Saland","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111521_bb0195","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00702-021-02349-5","article-title":"Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017","volume":"128","author":"Seifert","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.31887\/DCNS.2016.18.4\/ncutler","article-title":"Sex differences in the psychopharmacological treatment of depression","volume":"18","author":"Sramek","year":"2016","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2018.11.053","article-title":"Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain","volume":"398","author":"Thelen","year":"2019","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111521_bb0210","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0269881118793104","article-title":"Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness","volume":"32","author":"Thomas","year":"2018","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0215","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jad.2015.11.018","article-title":"Structural connectivity and response to ketamine therapy in major depression: A preliminary study","volume":"190","author":"Vasavada","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0220","author":"WHO"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111521_bb0225","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111521_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine\u2019s plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111521_bb0235","article-title":"Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:15:17Z","timestamp":1762265717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625002751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"alternative-id":["S0278584625002751"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111521","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in ketamine treatment for depressive disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111521"}}